案例研究

A world-class pharma facility for Saudi Arabia’s future

Wood is engineering solutions for a healthier world by partnering with global pharmaceutical, 生物技术, healthcare and re搜索 organisations providing expertise across the full asset life cycle.

  • linkedin图标
  • twitter图标
  • facebook的图标
  • youtube图标
  • instagram图标
项目详细信息
项目名称:
沙特阿拉伯制药设施
客户名称:
辉瑞
地点:
King Abdullah Economic City, Saudi Arabia
马可Bolognini
VP Business Development – EMEA and APAC 生命科学
安吉洛贝尔纳迪
Life-Science Global Technology Lead
弗雷德里克Jeunet
Vice President 生命科学 Australia
Christina Meyer Dell Cioppia
CQV副总裁
肯尼斯·L. Bibbo
Director, Emerging Technologies
关键统计数据
国家大小:
Saudi Arabia is largest country in the Gulf region
人口:
3300万年
Largest economy in Arab world:
国内生产总值782美元

When 辉瑞 needed a new manufacturing facility for the production and packaging of pharmaceuticals in Saudi Arabia, we partnered together with our client to provide a wide range of multidisciplinary services – from the earliest days of the project’s inception in 2010, through construction and production trials.

在这种情况下, the US-based pharmaceutical giant needed to meet requirements of a law that mandated international drug makers conduct a portion of their production process in-country. 这样做的时候, it would also enable 辉瑞 to sell its own products in Saudi Arabia’s pharmaceutical market, which is one of the largest in the Middle East.

Wood’s ability to draw on its extensive global expertise in pharmaceutical and life sciences, plus our multi-sector experience in local environments, 我们是如何增加项目价值的. To better answer client requests, Wood also built a multicultural team of engineers who worked in perfect integration with 辉瑞 corporate and local site teams along every step of the project.

That we were able to deliver wide-ranging services under one project management team – like, 场地总体规划, 概念及基本设计, 详细工程, 分包商的支持, technical support to the main contractor during the construction phase, plus final commissioning and qualification management – was a difference maker, 太, and that enabled us to more 关闭ly align with 辉瑞’s needs.

医药库房自动化

医药制造

Even in the early design stages, when project targets weren’t yet completely defined – and different ideas and visions needed to be considered – our project team provided effective support for a smooth decision process, 通过共享关键标准, 背景和备选方案. We followed that up with an extensive design-to-cost exercise, which involved a deep re-thinking of project requirements and site arrangement, as well as the quality of equipment and materials. The result was a substantially optimized project budget which was in line with our client’s financial targets.

The US $50M plant formally opened in 2017. Located in King Abdullah Economic City (KAEC) on the west coast of the Red Sea and about 100km north of Jeddah, 包括制造业, primary and secondary packaging, quality control labs and warehousing, as well as staff support spaces. With a total developed surface area in the range of 11,000 m2, it has the capacity to produce 18 million packs of solid dosage forms annually.

As part of 辉瑞’s wider network of major manufacturing facilities around the world, the initial focus of the Saudi facility was to produce 16 of the company’s core pharmaceutical products, 在不同的阶段, to meet local health needs in five therapeutic areas, 包括:心血管, 疼痛, 抗感染药, 泌尿外科和神经病学.

In addition to providing access to high quality medicines for a regional population that is growing and aging, 辉瑞’s local presence ensures the integrity of pharmaceutical supplies and reduces imports of medications. Saudi Arabia also reaps an added benefit. Of the initial 124 employees hired at 辉瑞’s Saudi manufacturing facility, 50%是沙特国民, ensuring the further development of local workers in this vital industry into the future.

相关主要市场
了解内情
保持联系
United by our common purpose to unlock solutions to the world’s most critical challenges, 我们为未来做好了准备, 现在.